Literature DB >> 29158033

Resident fibroblast expansion during cardiac growth and remodeling.

Malina J Ivey1, Jill T Kuwabara1, Jonathan T Pai2, Richard E Moore3, Zuyue Sun2, Michelle D Tallquist4.   

Abstract

Cardiac fibrosis, denoted by the deposition of extracellular matrix, manifests with a variety of diseases such as hypertension, diabetes, and myocardial infarction. Underlying this pathological extracellular matrix secretion is an expansion of fibroblasts. The mouse is now a common experimental model system for the study of cardiovascular remodeling and elucidation of fibroblast responses to cardiac growth and stress is vital for understanding disease processes. Here, using diverse but fibroblast specific markers, we report murine fibroblast distribution and proliferation in early postnatal, adult, and injured hearts. We find that perinatal fibroblasts and endothelial cells proliferate at similar rates. Furthermore, regardless of the injury model, fibroblast proliferation peaks within the first week after injury, a time window similar to the period of the inflammatory phase. In addition, fibroblast densities remain high weeks after the initial insult. These results provide detailed information regarding fibroblast distribution and proliferation in experimental methods of heart injury.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac fibroblast; Endothelial cell; Fibrosis; Proliferation

Mesh:

Substances:

Year:  2017        PMID: 29158033      PMCID: PMC5831691          DOI: 10.1016/j.yjmcc.2017.11.012

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  62 in total

1.  Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling.

Authors:  Christopher L Smith; Seung Tae Baek; Caroline Y Sung; Michelle D Tallquist
Journal:  Circ Res       Date:  2011-04-21       Impact factor: 17.367

2.  Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging.

Authors:  Svetlana Halfon; Natalie Abramov; Borislava Grinblat; Irene Ginis
Journal:  Stem Cells Dev       Date:  2010-10-26       Impact factor: 3.272

Review 3.  Cardiac fibroblasts: more than mechanical support.

Authors:  Stefanie A Doppler; Catarina Carvalho; Harald Lahm; Marcus-André Deutsch; Martina Dreßen; Nazan Puluca; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations.

Authors:  G Olivetti; P Anversa; A V Loud
Journal:  Circ Res       Date:  1980-04       Impact factor: 17.367

5.  Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution.

Authors:  A C Nag
Journal:  Cytobios       Date:  1980

6.  Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney.

Authors:  Asha Acharya; Seung Tae Baek; Serena Banfi; Banu Eskiocak; Michelle D Tallquist
Journal:  Genesis       Date:  2011-08-18       Impact factor: 2.487

7.  Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents.

Authors:  Antoni Bayes-Genis; Carolina Soler-Botija; Jordi Farré; Pilar Sepúlveda; Angel Raya; Santiago Roura; Cristina Prat-Vidal; Carolina Gálvez-Montón; José Anastasio Montero; Dirk Büscher; Juan Carlos Izpisúa Belmonte
Journal:  J Mol Cell Cardiol       Date:  2010-08-14       Impact factor: 5.000

8.  Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors.

Authors:  K Reiss; W Cheng; J Kajstura; E H Sonnenblick; L G Meggs; P Anversa
Journal:  Am J Physiol       Date:  1995-09

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

10.  Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

Authors:  Sarah M Williams; Lucy Golden-Mason; Bradley S Ferguson; Katherine B Schuetze; Maria A Cavasin; Kim Demos-Davies; Michael E Yeager; Kurt R Stenmark; Timothy A McKinsey
Journal:  J Mol Cell Cardiol       Date:  2013-12-26       Impact factor: 5.000

View more
  49 in total

1.  Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure.

Authors:  Yanzhen Li; Daniel Song; Lan Mao; Dennis M Abraham; Nenad Bursac
Journal:  Biomaterials       Date:  2020-01-29       Impact factor: 12.479

2.  Platelet-derived growth factor receptor-α is essential for cardiac fibroblast survival.

Authors:  Malina J Ivey; Jill T Kuwabara; Kara L Riggsbee; Michelle D Tallquist
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

3.  Cardiac fibroblast activation during myocardial infarction wound healing: Fibroblast polarization after MI.

Authors:  Michael J Daseke; Mavis A A Tenkorang; Upendra Chalise; Shelby R Konfrst; Merry L Lindsey
Journal:  Matrix Biol       Date:  2020-05-21       Impact factor: 11.583

4.  Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.

Authors:  Matthew S Stratton; Rushita A Bagchi; Marina B Felisbino; Rachel A Hirsch; Harrison E Smith; Andrew S Riching; Blake Y Enyart; Keith A Koch; Maria A Cavasin; Michael Alexanian; Kunhua Song; Jun Qi; Madeleine E Lemieux; Deepak Srivastava; Maggie P Y Lam; Saptarsi M Haldar; Charles Y Lin; Timothy A McKinsey
Journal:  Circ Res       Date:  2019-08-14       Impact factor: 17.367

5.  Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart.

Authors:  Shuaibo Huang; Bijun Chen; Ya Su; Linda Alex; Claudio Humeres; Arti V Shinde; Simon J Conway; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2019-05-11       Impact factor: 5.000

6.  Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts.

Authors:  Ryan M Burke; Janet K Lighthouse; Deanne M Mickelsen; Eric M Small
Journal:  Circ Heart Fail       Date:  2019-04       Impact factor: 8.790

7.  Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury.

Authors:  Nona Farbehi; Ralph Patrick; Aude Dorison; Munira Xaymardan; Vaibhao Janbandhu; Katharina Wystub-Lis; Joshua Wk Ho; Robert E Nordon; Richard P Harvey
Journal:  Elife       Date:  2019-03-26       Impact factor: 8.140

Review 8.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

Review 9.  Adding insult to injury - Inflammation at the heart of cardiac fibrosis.

Authors:  Sasha Smolgovsky; Udoka Ibeh; Tatiana Peña Tamayo; Pilar Alcaide
Journal:  Cell Signal       Date:  2020-11-06       Impact factor: 4.315

10.  HDAC Inhibition Reverses Preexisting Diastolic Dysfunction and Blocks Covert Extracellular Matrix Remodeling.

Authors:  Joshua G Travers; Sara A Wennersten; Brisa Peña; Rushita A Bagchi; Harrison E Smith; Rachel A Hirsch; Lauren A Vanderlinden; Ying-Hsi Lin; Evgenia Dobrinskikh; Kimberly M Demos-Davies; Maria A Cavasin; Luisa Mestroni; Christian Steinkühler; Charles Y Lin; Steven R Houser; Kathleen C Woulfe; Maggie P Y Lam; Timothy A McKinsey
Journal:  Circulation       Date:  2021-03-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.